Professor Nicholas Harvey, President of the International Osteoporosis Foundation, posits the urgent need to address the burden of bone health and the associated chronic conditions, which are putting immense strain on public health and health services.
Breakthrough research shows the brain doesn't drift into sleep gradually; it hits a sudden "tipping point." Discover how scientists pinpoint the second your brain shuts down each night.
A UK patient has become the first with multiple sclerosis (MS) to receive cutting-edge CAR T-cell therapy, as scientists test whether the one-time treatment can halt disease progression.
Last month, the UK Government published its long-awaited 10-Year Health Plan, with one of its three key shifts being the move from ‘analogue to digital’.
Researchers at UCL have developed a method to reduce MRI scan times for dementia diagnosis by two-thirds, potentially doubling daily scan capacity and improving access to early care.
University of Bristol researchers have discovered a VEGF-C gene therapy that protects the kidneys and may prevent serious complications in people with type 1 diabetes.
A UCL-led study shows bioactive nanoparticles can restore blood-brain barrier function and clear amyloid-β in mice, reversing Alzheimer's-like brain changes.
A new NHS screening programme will test babies for hereditary tyrosinemia type 1 at five days old, enabling early treatment to prevent organ damage, liver failure, and other serious complications.
The University of Birmingham leads £1.55m research to assess the long-term effects of vaping on respiratory cells, immunity, and lung microbiome in smokers.
The University of Liverpool researchers create a low-cost, handheld AI-powered blood test to detect Alzheimer's biomarkers, enabling earlier diagnosis and global accessibility.
